M.‐S. Doutre

4.1k total citations
131 papers, 1.4k citations indexed

About

M.‐S. Doutre is a scholar working on Dermatology, Rheumatology and Epidemiology. According to data from OpenAlex, M.‐S. Doutre has authored 131 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Dermatology, 35 papers in Rheumatology and 32 papers in Epidemiology. Recurrent topics in M.‐S. Doutre's work include Urticaria and Related Conditions (19 papers), Autoimmune Bullous Skin Diseases (18 papers) and Dermatology and Skin Diseases (12 papers). M.‐S. Doutre is often cited by papers focused on Urticaria and Related Conditions (19 papers), Autoimmune Bullous Skin Diseases (18 papers) and Dermatology and Skin Diseases (12 papers). M.‐S. Doutre collaborates with scholars based in France, Switzerland and United States. M.‐S. Doutre's co-authors include M. Beylot‐Barry, C Beylot, C Beylot, P Bioulac, O. Cogrel, J Beylot, Julien Sénéschal, Jean‐Luc Pellegrin, P Royer and Thierry Schaeverbeke and has published in prestigious journals such as The Lancet, PLoS ONE and Journal of Hepatology.

In The Last Decade

M.‐S. Doutre

114 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.‐S. Doutre France 20 479 437 405 317 284 131 1.4k
Thomas Harr Switzerland 18 411 0.9× 358 0.8× 357 0.9× 267 0.8× 816 2.9× 46 1.6k
J.C. Roujeau France 18 805 1.7× 941 2.2× 478 1.2× 277 0.9× 1.2k 4.1× 40 2.0k
Sylvia Hsu United States 23 460 1.0× 613 1.4× 1.0k 2.6× 326 1.0× 217 0.8× 142 2.2k
Hong‐Shang Hong Taiwan 19 513 1.1× 605 1.4× 693 1.7× 327 1.0× 988 3.5× 67 2.4k
Hirobumi Kondo Japan 25 516 1.1× 272 0.6× 77 0.2× 282 0.9× 149 0.5× 85 1.7k
R. P. Warin United Kingdom 18 523 1.1× 375 0.9× 198 0.5× 141 0.4× 107 0.4× 55 1.2k
Soheil Tavakolpour Iran 21 441 0.9× 611 1.4× 221 0.5× 190 0.6× 39 0.1× 86 1.5k
Mark Goodfield United Kingdom 27 725 1.5× 363 0.8× 863 2.1× 369 1.2× 54 0.2× 81 2.1k
J J Cream United Kingdom 23 396 0.8× 276 0.6× 443 1.1× 336 1.1× 34 0.1× 68 1.5k
George N. Papaliodis United States 19 458 1.0× 222 0.5× 77 0.2× 153 0.5× 241 0.8× 70 1.4k

Countries citing papers authored by M.‐S. Doutre

Since Specialization
Citations

This map shows the geographic impact of M.‐S. Doutre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.‐S. Doutre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.‐S. Doutre more than expected).

Fields of papers citing papers by M.‐S. Doutre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.‐S. Doutre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.‐S. Doutre. The network helps show where M.‐S. Doutre may publish in the future.

Co-authorship network of co-authors of M.‐S. Doutre

This figure shows the co-authorship network connecting the top 25 collaborators of M.‐S. Doutre. A scholar is included among the top collaborators of M.‐S. Doutre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.‐S. Doutre. M.‐S. Doutre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Milpied, B., A.‐S. Darrigade, Thomas Barnetche, et al.. (2023). Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study. Acta Dermato Venereologica. 103. adv3713–adv3713. 1 indexed citations
2.
Dousset, L., et al.. (2018). Long-lasting cutaneous tuberculosis owing to Mycobacterium bovis masquerading as sarcoidosis. JAAD Case Reports. 5(1). 1–4. 1 indexed citations
3.
Truchetet, Marie‐Elise, Valérie Jolivel, Isabelle Douchet, et al.. (2016). Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic Sclerosis. Arthritis & Rheumatology. 68(11). 2784–2794. 37 indexed citations
4.
Dutronc, H., Olivia Peuchant, Frédéric‐Antoine Dauchy, et al.. (2016). Nontuberculous Mycobacterial Infections in a French Hospital: A 12-Year Retrospective Study. PLoS ONE. 11(12). e0168290–e0168290. 27 indexed citations
5.
Doutre, M.‐S.. (2014). Urticaires systémiques en 2014. Annales de Dermatologie et de Vénéréologie. 141. S580–S585. 2 indexed citations
6.
Kostrzewa, E., et al.. (2009). Infection cutanée à Mycobacterium chelonae au cours d’un traitement par anti-TNF. Annales de Dermatologie et de Vénéréologie. 136(11). 811–814. 9 indexed citations
7.
Pham‐Ledard, Anne, B. Vergier, M.‐S. Doutre, & M. Beylot‐Barry. (2009). Disseminated Cutaneous Lymphoid Hyperplasia of 12 Years’ Duration Triggered by Vaccination. Dermatology. 220(2). 176–179. 10 indexed citations
8.
Doutre, M.‐S., et al.. (2005). Syndrome des ecchymoses douloureuses : une maladie psychogène. La Revue de Médecine Interne. 26(9). 744–747. 3 indexed citations
9.
Cogrel, O., et al.. (2004). Mucinose en bandes et sclérodermie systémique. Annales de Dermatologie et de Vénéréologie. 131(4). 361–364. 1 indexed citations
10.
Doutre, M.‐S., et al.. (2003). Prise en charge de l’urticaire chronique : recommandations de la conférence de consensus. La Revue de Médecine Interne. 24(10). 637–639. 6 indexed citations
11.
Maurice‐Tison, S., et al.. (2003). Médecins généralistes, dermatologues, allergologues et prise en charge de l'urticaire chronique. Résultats d'enquêtes de pratiques.. Annales de Dermatologie et de Vénéréologie. 130. 1 indexed citations
12.
Doutre, M.‐S.. (2002). [Ciclosporin].. PubMed. 129(4 Pt 1). 392–404. 3 indexed citations
13.
Bonnet, Fabrice, Philippe Morlat, X. Delbrel, et al.. (2001). Sarcoïdose et comorbidité : étude rétrospective de 32 observations. La Revue de Médecine Interne. 22(7). 619–623. 13 indexed citations
14.
Beylot‐Barry, M., et al.. (1998). Primary Cutaneous <i>Nocardia asteroides </i>Infection after Heart Transplantation. Dermatology. 196(2). 246–247. 13 indexed citations
15.
Beylot‐Barry, M., M.‐S. Doutre, O Blétry, & C Beylot. (1994). Bronchiolite oblitérante lupique : difficultés thérapeutiques. La Revue de Médecine Interne. 15(5). 332–335. 1 indexed citations
16.
Doutre, M.‐S., et al.. (1985). Xanthomes plans normolipémiques et myélome IgG kappa à activité anti-lipoprotéine. A propos d'un cas. Revue de la littérature.. Dermatology. 170(4). 157–164. 1 indexed citations
17.
Doutre, M.‐S., et al.. (1985). Xanthomes plans normolipémiques et myélome IgG&#x0138; à activité anti-lipoprotéine. Dermatology. 170(4). 157–164. 11 indexed citations
18.
Beylot, C, et al.. (1984). [Cutis marmorata telangiectatica congenita. Apropos of a case with hemicorporeal topography. Ultrastructural study].. PubMed. 111(4). 359–68. 3 indexed citations
19.
Beylot, C, P Bioulac, & M.‐S. Doutre. (1980). [Acute generalized exanthematic pustuloses (four cases) (author's transl)].. PubMed. 107(1-2). 37–48. 155 indexed citations
20.
Doutre, M.‐S., et al.. (1978). Pelade et trisomie 21. A propos de 2 cas.. Annales de Dermatologie et de Vénéréologie. 105. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026